Setting a New Standard
THE INTESTI CURC™ (Cur-cure™) CLINICAL TRIAL
Description
Curcumin in Combination With Mesalamine Induces
Remission in Patients With Mild-to-Moderate Ulcerative
Colitis in a Randomized Controlled Trial
Research & Development
More researches
Berberine alone and in conjunction…
BERBERINE ALONE AND IN CONJUNCTION WITH IMMUNOMODULATORS DOWN-REGULATES PRO-INFLAMMATORY CD4+T-CELLS: IMPLICATIONS FOR…
Read more
Curcumin, but not mesalamine
Curcumin, but not mesalamine, inhibits activated T-cells: Implications for combo curcumin-mesalamine UC therapy. Gastroenterology Unit, Sheba Medical Center…
Read more
Curcumin add-on therapy…
Curcumin add-on therapy for remission induction in mild-moderate active ulcerative colitis: A Multi-Center, Randomized, Placebo-Controlled Trial…
Read more
The multi-center international clinical…
The multi-center international clinical trial of CurCure™ food supplement for the treatment of patients with inflammation of the gut (a condition called ulcerative...
Read more